In the recent years, the medical field has been trying to come up with ways to increase the sarcoma cancer survival rate, but without much luck. As of today, the sarcoma cancer survival rate is still amongst the lowest in all cancer types and seemed to continually decline as more studies are conducted.

Sarcoma may equally develop on both adults and children and may start at any parts of the body. Most sarcomas arise from soft tissues and bones with 60% starting from our extremities, 30% on the middle body part like the abdomen, and 10% from the head and neck. Not many people acquire this cancer – Cancer.net reports that only 1% of all adult cancer cases are sarcoma. However, the disease is quite high in children at around 15%.

The most common type of sarcoma is soft-tissue sarcoma which arises from connective tissues in our body. This type of sarcoma is pretty common because it naturally occurs at any parts of the body.

A 5 year sarcoma cancer survival rate is the ratio between the number of patients with sarcoma who are still alive 5 years after being diagnosed to the number of those who didn’t make it. Regardless of the stage or type of sarcoma cancer, the sarcoma cancer survival rate is relatively 50-50 so 1 out of 2 patients live more than 5 years with adequate cure.

Some researchers argue with this result because there are types of sarcomas that are naturally more critical compared to the other types.

Eighty three percent of those patients who were diagnosed at the first stage of the cancer were able to survive until 5 years. Treatment at this stage usually includes surgery and a couple of chemotherapy sessions. Four out of five patients remain living because at this stage, the cancer is very easy to remove since it is still confined at one part of the body.

It’s when the sarcoma begins spreading out of other tissues that the sarcoma survival rate may become quite lower. And at the final stage, only 1 out of 8 people survive the cancer and add 5 or more years in their lives.

The good thing is more than half of the patients with sarcoma are diagnosed at the first stages. Hopefully, this will increase more with the help of more advanced equipments and more medical missions to propagate awareness of sarcoma cancer not just in the US but also worldwide.